A study for a 39 year old man who takes Stribild - from FDA reports


Summary

126 males aged 39 (±5) who take the same drug are studied. This is a personalized study for a 39 year old male patient who has Hiv. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Aug, 03, 2017

126 males aged 39 (±5) who take Stribild are studied.


Number of reports submitted per year:

Stribild for a 39-year old man.

Information of the patient in this study:

  • Age: 39
  • Gender: male
  • Conditions: Hiv
  • Drugs taken:
    • Stribild (cobicistat; elvitegravir; emtricitabine; tenofovir disoproxil fumarate)

eHealthMe real world results:

Most common side effects over time

< 1 month:
  • headache
  • muscle aches
  • pain
  • itching
  • diarrhea
  • chest pain
  • rashes
  • anaphylaxis
  • the flu
  • dizziness
1 - 6 months:
  • mucosal haemorrhage
  • haemorrhage subcutaneous
  • drug ineffective
  • rashes
  • laryngeal haematoma
  • anaphylaxis
  • joint pain
  • hair color changes
  • viral load increased
  • genital herpes
6 - 12 months:
  • muscle aches
  • rashes
  • joint pain
  • rash pruritic
  • skin toxicity
  • seizures
  • gastric ulcer
  • burning sensation
  • blood creatinine increased
  • toothaches
1 - 2 years:
n/a
2 - 5 years:
  • osteopenia
  • osteoporosis
5 - 10 years:
n/a
10+ years:
n/a
not specified:
  • diarrhea
  • adrenal suppression
  • nausea
  • fatigue
  • nausea and vomiting
  • dizziness
  • blood creatinine increased
  • pain
  • headache
  • weakness

Top conditions involved for these people *:

  • High Blood Pressure (6 people, 4.76%)
  • Nasal Congestion (4 people, 3.17%)
  • Insomnia (3 people, 2.38%)
  • Hiv Test Positive (3 people, 2.38%)
  • Factor Viii Deficiency (3 people, 2.38%)

Top co-used drugs for these people *:

  • Truvada (11 people, 8.73%)
  • Atripla (11 people, 8.73%)
  • Norvir (5 people, 3.97%)
  • Prezista (4 people, 3.17%)
  • Isentress (4 people, 3.17%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

Related studies:

Can you answer these questions?

More questions for: Stribild, Hiv

You may be interested in these reviews

More reviews for: Stribild, Hiv